21 Apr 2017 07:00
Â
Instem plc
Â
("Instem")
Â
Posting of Annual Report and Accounts & Notice of AGM
Â
Instem (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that it has today posted to shareholders its Annual Report and Accounts for the year ended 31 December 2016, together with the Notice of Annual General Meeting, which is to be held at 10:00 a.m. on Thursday 18 May 2017, at the offices of RSM, 3 Hardman Street, Manchester, M3 3HF.
Â
A copy of the Annual Report and Accounts is available on Instem's website at http://investors.instem.com.
Â
For further information, please contact:
Â
Instem plc | +44 (0) 1785 825 600 |
Phil Reason, CEO | |
Nigel Goldsmith, CFO | |
N+1 Singer (Nominated Adviser & Broker) | +44 (0) 20 7496 3000 |
Richard Lindley James White | |
Walbrook Financial PR | +44 (0) 20 7933 8000 |
Paul Cornelius | instem@walbrookpr.com |
Helen Cresswell Sam Allen Paul Whittington | |
Â
Â
About Instem
Â
About Instem plc
Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Â
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
Â
To learn more about Instem solutions and its mission, please visit www.instem.com